Current Assets

Accounts Receivable

IQVIA Accounts Receivable decreased by 1.6% to $3.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $3.27B to $3.35B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 7.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026

How to read this metric

Rapid growth relative to sales may indicate collection issues or aggressive revenue recognition; stability suggests efficient cash conversion.

Detailed definition

This represents the total amount owed to the company by customers for goods or services delivered, minus the allowance f...

Peer comparison

Standard metric for all companies with B2B or credit-based sales models.

Metric ID: accounts_receivable_net

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.28B$2.33B$2.55B$2.62B$2.68B$2.64B$2.92B$3.06B$3.14B$3.23B$3.38B$3.43B$3.26B$3.20B$3.20B$3.27B$3.34B$3.27B$3.40B$3.35B
QoQ Change+2.4%+9.5%+2.7%+2.3%-1.5%+10.5%+5.0%+2.5%+2.8%+4.8%+1.3%-5.0%-1.8%+0.3%+2.0%+2.3%-2.2%+4.0%-1.6%
YoY Change+17.7%+13.3%+14.3%+17.0%+17.2%+22.2%+15.9%+11.9%+3.7%-1.0%-5.2%-4.6%+2.7%+2.3%+6.1%+2.4%
Range$2.28B$3.43B
CAGR+8.5%
Avg YoY Growth+8.5%
Median YoY Growth+9.0%

Frequently Asked Questions

What is IQVIA's accounts receivable?
IQVIA (IQV) reported accounts receivable of $3.35B in Q1 2026.
How has IQVIA's accounts receivable changed year-over-year?
IQVIA's accounts receivable increased by 2.4% year-over-year, from $3.27B to $3.35B.
What is the long-term trend for IQVIA's accounts receivable?
Over 5 years (2020 to 2025), IQVIA's accounts receivable has grown at a 7.1% compound annual growth rate (CAGR), from $2.41B to $3.40B.
What does accounts receivable mean?
The net amount of money owed by customers after accounting for potential non-payments.